Companies: 10,795·Total market cap: $144.5T

MediWound Ltd.

MediWound Ltd.

MDWDNASDAQHealthcare● Active

$14.54

+$0.36(+2.54%)

Market Cap$157948063

P/E Ratio—

52W High$22.09

52W Low$13.54

Avg Volume93K

Open$14.18

Beta0.15

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

MediWound Ltd.（MDWD）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · MDWD · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-2.26Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)$14.5MFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding11.4MShares outstanding history

Next EarningsAug 13, 2026Est.Earnings history

探索 MediWound Ltd. 数据

分析师预测$27 · Buy

股息不分红

营收$17.0M-16.14%

盈利EPS $-2.10+30.69%

财务快照

FY 2025Revenue$17.0M▼ 16.14% YoY

202320242025

FY 2025Net Income-$23.9M▲ +20.99% YoY

202320242025

FY 2025EPS$-2.10▲ +30.69% YoY

202320242025

TTM:Revenue: $14.5MNet Income: -$26.1MEPS: $-2.26View income statement →

分析师评级与目标价

Buy13 位分析师

Strong Buy

0

Buy

13

Hold

0

Sell

0

Strong Sell

0

12-Month Price Target

$22.00Low

$14.54Current

$27.00Avg Target上涨空间 85.69%

$32.00High

合计: 13 · 买入占比: 100.0%

根据过去 3 个月内 13 位华尔街分析师，MDWD 共识评级为 Buy，12 个月平均目标价 $27.00 （较现价 $14.54 上涨空间 85.69%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

$14.54+2.54%$157.9M #2

Aardvark Therapeutics, Inc. Common Stock

$3.59-1.22%$78.3M #3

Eupraxia Pharmaceuticals Inc.

$6.01+1.34%$201.2M #4

$8.95+4.07%$445.7M #5

$3.89-3.97%$202.0M #6

$1.05-0.49%$139.4M

股票表现

1D+2.33%

1W+5.14%

1M-12.43%

3M-14.80%

YTD-21.40%

1Y-32.39%

5Y-43.98%

关于 MediWound Ltd.

CEOOfer Gonen

IPO DateMar 20, 2014

Employees111

CountryIL

Websitemediwound.com

MediWound Ltd. a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical…

Biotechnology HealthcareNASDAQIL

关于股票概览与关键数据

MediWound Ltd.（MDWD）是 Biotechnology 行业的 Healthcare 类公司，于 Mar 20, 2014 在 NASDAQ 上市。截至最近交易日，MDWD 股价为 $14.54，市值约为 $157.9M。过去12个月累计回报 -32.39%，年初至今回报 -21.40%。

根据 13 位华尔街分析师，MediWound Ltd. 股票共识评级为Buy，12个月平均目标价为 $27.00。2025 财年 MediWound Ltd. 营收 $17.0M，净利润 -$23.9M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，MediWound Ltd.（MDWD）股价为 $14.54，在 NASDAQ 上市，52周区间为 $13.54 – $22.09。

MDWD 最新股价MDWD quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议